MRKR Shares

Marker Therapeutics Inc (MRKR) with a beta value of 1.44 appears to be a promising investment opportunity.
Sana Meer
On Monday, Marker Therapeutics Inc (NASDAQ: MRKR) opened higher 16.23% from the last session, before settling in for the closing ...





